If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Neoplasms Medicine & Life Sciences
Cancer Vaccines Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Granulocyte-Macrophage Colony-Stimulating Factor Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Fabry Disease Medicine & Life Sciences
Clinical Trials, Phase I Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2018

  • 475 Citations
  • 12 h-Index
  • 23 Article
  • 1 Chapter
  • 1 Comment/debate
  • 1 Review article

A novel combination therapy for human oxaliplatin-resistant colorectal cancer using oxaliplatin and coxsackievirus A11

Wang, B., Ogata, H., Takishima, Y., Miyamoto, S., Inoue, H., Kuroda, M., Yamada, K., Hijikata, Y., Murahashi, M., Shimizu, H., Okazaki, T., Nakanishi, Y. & Tani, K., Nov 1 2018, In : Anticancer research. 38, 11, p. 6121-6126 6 p.

Research output: Contribution to journalArticle

oxaliplatin
Enterovirus
Colorectal Neoplasms
Coxsackievirus Infections
Therapeutics
1 Citation (Scopus)

A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors

Hijikata, Y., Okazaki, T., Tanaka, Y., Murahashi, M., Yamada, Y., Yamada, K., Takahashi, A., Inoue, H., Kishimoto, J., Nakanishi, Y., Oda, Y., Nakamura, Y. & Tani, K., Jan 1 2018, In : PloS one. 13, 1, e0187878.

Research output: Contribution to journalArticle

Clinical Trials, Phase I
cyclophosphamide
Cell- and Tissue-Based Therapy
Cyclophosphamide
Fingers
1 Citation (Scopus)

Identification of tumoricidal TCRs from tumor-infiltrating lymphocytes by single-cell analysis

Shitaoka, K., Hamana, H., Kishi, H., Hayakawa, Y., Kobayashi, E., Sukegawa, K., Piao, X., Lyu, F., Nagata, T., Sugiyama, D., Nishikawa, H., Tanemura, A., Katayama, I., Murahashi, M., Takamatsu, Y., Tani, K., Ozawa, T. & Muraguchi, A., Apr 1 2018, In : Cancer Immunology Research. 6, 4, p. 378-388 11 p.

Research output: Contribution to journalArticle

Single-Cell Analysis
Tumor-Infiltrating Lymphocytes
T-Cell Antigen Receptor
Neoplasm Antigens
Neoplasms

RBPJ and MAML3: Potential therapeutic targets for small cell lung cancer

Ohnishi, H., Ichimiya, S., Yanai, K., Umebayashi, M., Nakamura, K., Yamasaki, A., Imaizumi, A., Nagai, S., Murahashi, M., Ogata, H. & Morisaki, T., Aug 1 2018, In : Anticancer research. 38, 8, p. 4543-4547 5 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
gemcitabine
Therapeutics
Matrix Metalloproteinases
Pancreatic Neoplasms
21 Citations (Scopus)

Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors

Murahashi, M., Hijikata, Y., Yamada, K., Tanaka, Y., Kishimoto, J., Inoue, H., Marumoto, T., Takahashi, A., Okazaki, T., Takeda, K., Hirakawa, M., Fujii, H., Okano, S., Morita, M., Baba, E., Mizumoto, K., Maehara, Y., Tanaka, M., Akashi, K., Nakanishi, Y. & 5 othersYoshida, K., Tsunoda, T., Tamura, K., Nakamura, Y. & Tani, K., May 1 2016, In : Clinical Immunology. 166-167, p. 48-58 11 p.

Research output: Contribution to journalArticle

Clinical Trials, Phase I
Cancer Vaccines
Subunit Vaccines
Neoplasm Antigens
Cyclophosphamide